All In Biotech

Drug Trial Radar · NCT01138514

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd., Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to a Comparator Clindamycin / Benzoyl Peroxide Topical Gel, and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Oct 13, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,555 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,555

Actual

Start

Oct 2009

Primary completion

Oct 2010

Study completion Oct 2010

Sponsor

Lead sponsor
Padagis LLCIndustry
Sponsor type
Industry
First posted
Jun 7, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).

Conditions

  • Acne Vulgaris

Interventions

  • Clindamycin 1% / Benzoyl Peroxide 5% (Perrigo)Drug

    Applied to the entire face twice daily for 10 weeks

  • Clindamycin 1% / Benzoyl Peroxide 5% (Benzaclin)Drug

    Applied to the entire face twice daily for 10 weeks

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Inflammatory LesionsTime frame: 10 weeks
  2. Percent Change From Baseline in Non-inflammatory LesionsTime frame: 10 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.